Literature DB >> 26375252

Protein-Protein Interfaces in Viral Capsids Are Structurally Unique.

Shanshan Cheng1, Charles L Brooks2.   

Abstract

Viral capsids exhibit elaborate and symmetrical architectures of defined sizes and remarkable mechanical properties not seen with cellular macromolecular complexes. Given the uniqueness of the higher-order organization of viral capsid proteins in the virosphere, we explored the question of whether the patterns of protein-protein interactions within viral capsids are distinct from those in generic protein complexes. Our comparative analysis involving a non-redundant set of 551 inter-subunit interfaces in viral capsids from VIPERdb and 20,014 protein-protein interfaces in non-capsid protein complexes from the Protein Data Bank found 418 generic protein-protein interfaces that share similar physicochemical patterns with some protein-protein interfaces in the capsid set, using the program PCalign we developed for comparing protein-protein interfaces. This overlap in the structural space of protein-protein interfaces is significantly small, with a p-value <0.0001, based on a permutation test on the total set of protein-protein interfaces. Furthermore, the generic protein-protein interfaces that bear similarity in their spatial and chemical arrangement with capsid ones are mostly small in size with fewer than 20 interfacial residues, which results from the relatively limited choices of natural design for small interfaces rather than having significant biological implications in terms of functional relationships. We conclude based on this study that protein-protein interfaces in viral capsids are non-representative of patterns in the smaller, more compact cellular protein complexes. Our finding highlights the design principle of building large biological containers from repeated, self-assembling units and provides insights into specific targets for antiviral drug design for improved efficacy.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  biological containers; capsid shells; drug specificity; protein–protein interaction; structural comparison

Mesh:

Substances:

Year:  2015        PMID: 26375252      PMCID: PMC4624513          DOI: 10.1016/j.jmb.2015.09.008

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  52 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 2.  Are weak protein-protein interactions the general rule in capsid assembly?

Authors:  Adam Zlotnick
Journal:  Virology       Date:  2003-10-25       Impact factor: 3.616

3.  The HIV-1 capsid protein C-terminal domain in complex with a virus assembly inhibitor.

Authors:  François Ternois; Jana Sticht; Stéphane Duquerroy; Hans-Georg Kräusslich; Félix A Rey
Journal:  Nat Struct Mol Biol       Date:  2005-07-24       Impact factor: 15.369

4.  Distinguishing reversible from irreversible virus capsid assembly.

Authors:  Adam Zlotnick
Journal:  J Mol Biol       Date:  2006-11-11       Impact factor: 5.469

5.  Do viral proteins possess unique biophysical features?

Authors:  Nobuhiko Tokuriki; Christopher J Oldfield; Vladimir N Uversky; Igor N Berezovsky; Dan S Tawfik
Journal:  Trends Biochem Sci       Date:  2008-12-04       Impact factor: 13.807

6.  Tilable nature of virus capsids and the role of topological constraints in natural capsid design.

Authors:  Ranjan V Mannige; Charles L Brooks
Journal:  Phys Rev E Stat Nonlin Soft Matter Phys       Date:  2008-05-01

Review 7.  Protein-protein interactions in the rigor actomyosin complex.

Authors:  R A Milligan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

Review 8.  Functional implications of protein-protein interactions in icosahedral viruses.

Authors:  J E Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

9.  Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment.

Authors:  T Stehle; Y Yan; T L Benjamin; S C Harrison
Journal:  Nature       Date:  1994-05-12       Impact factor: 49.962

10.  Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design.

Authors:  R A Grant; C N Hiremath; D J Filman; R Syed; K Andries; J M Hogle
Journal:  Curr Biol       Date:  1994-09-01       Impact factor: 10.834

View more
  3 in total

1.  Electrostatics-Driven Inflation of Elastic Icosahedral Shells as a Model for Swelling of Viruses.

Authors:  Anže Lošdorfer Božič; Antonio Šiber
Journal:  Biophys J       Date:  2018-08-07       Impact factor: 4.033

2.  C22 podovirus infectivity is associated with intermediate stiffness.

Authors:  Udom Sae-Ueng; Anjana Bhunchoth; Namthip Phironrit; Alongkot Treetong; Chaweewan Sapcharoenkun; Orawan Chatchawankanphanich; Ubolsree Leartsakulpanich; Penchit Chitnumsub
Journal:  Sci Rep       Date:  2020-07-28       Impact factor: 4.379

Review 3.  In vitro methods for testing antiviral drugs.

Authors:  Michaela Rumlová; Tomáš Ruml
Journal:  Biotechnol Adv       Date:  2017-12-29       Impact factor: 14.227

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.